跳至主要内容
临床试验/IRCT20211104052968N1
IRCT20211104052968N1已完成2 期

Effcacy of lacosomide on refractory focal seizures as add on therapy in children aged 6 months to 16 years

Esfahan University of Medical Sciences0 个研究点目标入组 44 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
入组人数
44

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
6 months 至 16 years(—)
性别
All

入选标准

  • All children from 6 months to 16 years of age with focal seizures who have been diagnosed with at least one previous electroencephalogram and do not respond well to routine treatments despite appropriate treatment with at least two anticonvulsants within 8 weeks of enrollment. They have had at least two relapses in four weeks and have not been in complete control for three weeks, and have not changed their doses of other anticonvulsant drugs in the two weeks prior to enrollment.

排除标准

  • Previous administration of lacosamide as an anticonvulsant for at least two months prior to the examination
  • renal deaseies
  • Inability to tolerate the drug due to side effects
  • Seizures caused by a progressive brain or neurodegenerative disease

研究者

相似试验